Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 647-654

  Weldon, William C ^a   Martin, Maria P ^a   Zarnitsyn, Vladimir ^b   Wang, Baozhong ^a   Koutsonanos, Dimitrios ^a   Skountzou, Ioanna ^a   Prausnitz, Mark R ^b   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT INFLUENZA VIRUS HEMAGGLUTININ VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HUMORAL IMMUNITY; IMMUNITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; LUNG PARENCHYMA; MATERIAL COATING; MICRONEEDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; TH1 CELL; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; TH1 CELLS; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL LOAD;

EID: 79954531900     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00435-10     Document Type: Article

References (41)

1. Alarcon, J. B., A. W. Hartley, N. G. Harvey, and J. A. Mikszta. 2007. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin. Vaccine Immunol. 14:375-381.
2. Baldwin, S. L., et al. 2009. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate. Vaccine 27:3063-3071.
3. Chau, K. F., et al. 2004. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination. Am. J. Kidney Dis. 43:910-917.
4. Chen, D., et al. 2003. Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine 21:2830-2836. (Pubitemid 36703194)
5. Coffman, R. L., H. F. Savelkoul, and D. A. Lebman. 1989. Cytokine regulation of immunoglobulin isotype switching and expression. Semin. Immunol. 1:55-63.
6. Cornelissen, L. A., et al. 2010. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5:e10645.
7. Cottey, R., C. A. Rowe, and B. S. Bender. 2001. Influenza virus. Curr. Protoc. Immunol., chapter 19, unit 19.11.
8. De Filette, M., et al. 2008. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J. Biol. Chem. 283:11382-11387.
9. Duggan, S. T., and G. L. Plosker. 2010. Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged ≥60 years). Drugs Aging 27:597-605.
10. Furio, L., I. Briotet, A. Journeaux, H. Billard, and J. Peguet-Navarro. 2010. Human Langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells. J. Invest. Dermatol. 130: 1345-1354.
11. Gill, H. S., D. D. Denson, B. A. Burris, and M. R. Prausnitz. 2008. Effect of microneedle design on pain in human volunteers. Clin. J. Pain 24:585-594.
12. Gill, H. S., and M. R. Prausnitz. 2007. Coated microneedles for transdermal delivery. J. Control. Release 117:227-237.
13. Hobson, D., R. L. Curry, A. S. Beare, and A. Ward-Gardner. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70:767-777.
14. Janssen, E. M., et al. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852-856. (Pubitemid 36254145)
15. Kenney, R. T., S. A. Frech, L. R. Muenz, C. P. Villar, and G. M. Glenn. 2004. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351:2295-2301.
16. Kim, Y. C., et al. 2009. Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine 27:6932-6938.
17. Koutsonanos, D. G., et al. 2009. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4:e4773.
18. Matriano, J. A., et al. 2002. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19:63-70.
19. Miller, L. S., and R. L. Modlin. 2007. Toll-like receptors in the skin. Semin. Immunopathol. 29:15-26.
20. Nestle, F. O., P. Di Meglio, J. Z. Qin, and B. J. Nickoloff. 2009. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-691.
21. Osinubi, M. O., et al. 2009. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications. Vaccine 27:7214-7218.
22. Prausnitz, M. R., and R. Langer. 2008. Transdermal drug delivery. Nat. Biotechnol. 26:1261-1268.
23. Quan, F. S., et al. 2010. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J. Virol. 84:7760-7769.
24. Quan, F. S., et al. 2009. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One 4:e7152.
25. Quan, F. S., A. Vunnava, R. W. Compans, and S. M. Kang. 2010. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One 5:e9161.
26. Reinhardt, R. L., H. E. Liang, and R. M. Locksley. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10:385-393.
27. Renegar, K. B., P. A. Small, Jr., L. G. Boykins, and P. F. Wright. 2004. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173:1978-1986.
28. Rodriguez, A., et al. 2005. Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23:2565-2572. (Pubitemid 40380800)
29. Rowe, T., et al. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
30. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
31. Sha, Z., and R. W. Compans. 2000. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J. Virol. 74:4999-5005.
32. Skountzou, I., F. S. Quan, J. Jacob, R. W. Compans, and S. M. Kang. 2006. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine 24:6110-6119.
33. Spiekermann, G. M., et al. 2002. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J. Exp. Med. 196:303-310.
34. Streilein, J. W. 1983. Skin-associated lymphoid tissues (SALT): origins and functions. J. Invest. Dermatol. 80(Suppl.):12s-16s.
35. Sullivan, S. P., et al. 2010. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 16:915-920.
36. Valladeau, J., and S. Saeland. 2005. Cutaneous dendritic cells. Semin. Immunol. 17:273-283.
37. Weldon, W. C., et al. 2010. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 5(9):e12466.
38. World Health Organization. 2002, posting date. WHO manual on animal influenza diagnosis and surveillance. World Health Organization, Geneva, Switzerland. http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98- 97937B4FA83C/0/manualonanimalaidiagnosisandsurveillance.pdf.
39. Yang, X., et al. 2000. Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J. Virol. 74:4746-4754. (Pubitemid 30237902)
40. Yin, H. S., X. Wen, R. G. Paterson, R. A. Lamb, and T. S. Jardetzky. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38-44.
41. Zhu, Q., et al. 2009. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc. Natl. Acad. Sci. U. S. A. 106:7968-7973.